Introduction
absence of a helper virus such as adenovirus, AAV causes Neoplastic transformation involves multiple genetic a latent infection characterized by the integration of viral events that include activation of proto-oncogenes and DNA into the cellular genome. The major advantages of inactivation of tumor-suppressor genes. Mutations of p53 recombinant AAV (rAAV) vectors include a lack of tumor suppressor gene are the most common abnormalipathogenicity in humans, 10 the ability of wild-type AAV ties yet identified in human cancers.
1,2 The p53 gene occuto integrate stably into the long arm of chromosome 19, 11 pies 16-20 kb of cellular DNA on the short arm of the potential ability to infect nondividing cells, 12, 13 and a chromosome 17 and encodes a 393-amino acid nuclear broad range of infectivity. 9, 10 We were interested in phosphoprotein involved in the regulation of cell prostudying the ability of rAAV vectors to infect human canliferation. The documented functions of p53 protein cer cells. We constructed a recombinant adeno-associated include cell cycle checkpoint regulation and induction of viral vector bearing the cDNA of wt p53 driven by the apoptosis. 3 The wt p53 induced growth arrest is partially Rous sarcoma virus (RSV) promoter and, neomycin phosmediated by the cyclin-dependent kinase inhibitor p21 4, 5 photransferase gene (neo R ) driven by the thymidine kinwhile the p53-dependent apoptosis pathway may involve ase (tk) promoter. In this report, we describe the antithe apoptosis regulating genes bcl-2 and bax. 6, 7 Several tumor efficacy of rAAVp53 in a cancer cell line with a previous studies, using recombinant retroviruses and homozygous deletion of p53 gene. This is the first adenoviruses, have demonstrated that introduction of wt reported use of rAAV in successful transduction of a p53 by virus-mediated delivery can suppress growth in tumor suppressor gene. a number of human cancer cell lines in vitro and in vivo. 3, 8 Adeno-associated viruses (AAV) are single stranded DNA parvoviruses. 9 The viral genome consists of rep
Results
genes encoding regulatory proteins and cap genes that encode the capsid proteins. The wild-type AAV-2 genrAAV-mediated gene transfer in H-358 cells ome is 4680 nucleotides (nt) in length. The coding region H-358 cells, a human non-small cell lung cancer-derived is flanked by 145 nt inverted terminal repeat sequences cell line that lacks endogenous p53, 14 was used to deterwhich are the minimum cis-acting elements essential for mine the expression of wt p53 following infection by rAAV. The rAAV vector carrying a ␤-galactosidase (␤-gal) reporter gene was used to test rAAV's ability to infect and transduction efficiency in H-358 cells. 15 Incu-␤-gal gene in 60-70% of the cells within 24 h (Figure 1 ). slower rate than the uninfected cells. These results suggest that infection with rAAVp53 either inhibited the H-358 cells infected with rAAV control showed no nuclear staining. These data established that viral uptake growth or reduced the viability of cells that were initially deficient in wt p53. and rAAV-mediated gene expression could be achieved at high efficiency in H-358 cells.
Similar studies were performed using a 7-day colorimetric assay as described in Materials and methods. In this assay, H-358 cells were grown in the presence of Characterization of rAAVp53 rAAVp53-transduced D6 clones selected in G418 were increasing concentrations of rAAVp53 and rAAVcontrol (MOI of 0.1, 1 and 10). As shown in Figure 3b , H-358 cells expanded and characterized by Southern blot analysis of genomic DNA. After digestion with SphI, the genomic were quite sensitive to the inhibitory effects of rAAVp53 with less than 50% cells surviving after 1 week of DNA was hybridized with a probe that recognizes a fragment of the neomycin phosphotransferase gene. The exposure to a MOI of 10 viral particles per cell. There was only a 10% inhibition of H-358 cells exposed to expected 3.1 kb fragment was detected in all the clones, indicating unrearranged proviral DNA (data not shown).
rAAVcontrol. Western blot analysis using mouse anti-human p53 is shown in Figure 2a . rAAVp53-infected H-358 cells rAAVp53 induced apoptosis p53 expression has been associated with both cell cycle expressed wt p53 at levels comparable to the endogenous wt p53 expressed in the MCF-7 cells (which express wt arrest and apoptosis. We therefore also examined the possible induction of apoptosis in H-358 cells following p53). There was no detectable p53 in the uninfected or rAAV control infected H-358 cells.
infection with rAAVp53. Cells were incubated with rAAVp53 or rAAV control (MOI of 10 infectious viral We also analyzed the expression of two p53-inducible cellular proteins including p21, an inhibitor of cyclinparticles per cell) for 24 h. The cells were then fixed with paraformaldehyde and stained with DAPI to identify the dependent kinases, 16, 17 and mdm2, a protein that binds to and regulates the activity of p53. 18 As shown in Figure  cells undergoing apoptosis. Each assay was performed in triplicate and 100 cells were counted in each chamber. As 2b and c, the basal level of p21 and mdm2, is very low to indetectable in uninfected H-358 cells in comparison shown in Figure 3c , exposure of H-358 cells to rAAVp53 triggered apoptosis as characterized by the appearance of to the MCF-7 cell line. Transduction of H-358 with rAAVp53, at a MOI of 1, resulted in a significant increase nuclear shrinkage, chromatin condensation and nuclear fragmentation in more than 70% of the cells. Cells in the expression of p21 and mdm2 proteins.
infected by rAAV control and uninfected cells failed to show these morphological changes. Inhibition of cell growth and cytotoxicity To assess the effects of rAAVp53 on cell growth, H-358 cells were incubated with rAAVp53 or rAAV control
Effect of rAAVp53 on cell cycle H-358 cells were analyzed for cell cycle phase distri-(MOI of 1-2) for a period of 24 h. The medium was then changed and the cells were incubated for a total of 7 days.
bution by propidium iodide staining and flow cytometry as described in Materials and methods. As shown in FigEach day, cells were harvested from sample plates and counted. H-358 cells treated with rAAVp53 were reduced ure 4, there was no significant difference in cell cycle phase distribution between the mock-infected cells and in number by day 4 (Figure 3a) , and by day 7 less than a half of total cells plated on day 0 were present. In conthe cells infected by the rAAV control. In contrast, H-358 cells infected with rAAVp53, showed a marked decrease trast, H-358 cells infected with the rAAV control, continued to grow and proliferate albeit at a somewhat in the proportion of cells in S phase (from 19 to 7%) and a significant increase in the proportion of cells in G1 (from 74 to 89%) and G2 (from 6 to 17%) phases. These results indicate that expression of wt p53 results in the arrest of H-358 cells at the G1-S and G2-M checkpoints.
Inhibition of tumor growth in vivo
To determine the effect of rAAVp53 in vivo, 1 × 10 5 H-358 tumor cells were injected subcutaneously into immunodeficient nu/nu mice and allowed to grow. Tumor nodules reproducibly developed at the injection site approximately 1 week later. Once tumors were 3-4 mm 2 in size, they were injected with 100 l of either PBS, rAAV control, or rAAVp53 (1 × 10 5 viral particles). Treatment with rAAVp53 resulted in marked inhibition of tumor growth and we were unable to detect macroscopic tumors in three of five mice with previously detectable nodules (Figure 5a and b). Of the two remaining animals in the rAAVp53 group, one had a slowly growing tumor and the other had a detectable but nongrowing tumor. In contrast, untreated and rAAV control virus treated tumors grew uninhibited. The possibility of wild-type adenovirus contamination of the rAAV preparations causing tumor cytotoxicity was excluded. Several cell lines (A549, HeLa, 293 and MCF-7), known to be sensitive to adenovirus infection, were incubated with dilutions of rAAVp53. No cytopathogenicity was observed after 10-14 days in culture.
To demonstrate the presence of wt p53 in these tumors an immunohistochemical assay was performed. H-358 tumors grown in nu/nu mice were harvested 5 days after intratumor injection. Immunoreactivity for wt p53 was observed only in tumors injected with rAAVp53. The antibody specific to wt p53 was confined to the nuclei and characterized by a brown reaction product. This wt p53 immunoreactivity was observed in 10-20% of the remaining tumor cells counted ( Figure 6 ). As expected, tumors injected with PBS or rAAV control failed to show any nuclear staining for wt p53 antigen.
Discussion
This report demonstrates that recombinant AAV vectors can be used effectively in vitro and in vivo for cancer gene therapy. The introduction of wt p53 by rAAVp53 into H-358 cells, which contain a homozygous deletion for p53, results in marked inhibition of cell growth in vitro and in vivo. The slow growth rate is associated with overexpression of wt p53 protein and induction of p21. The p21 protein inhibits CDK/cyclin complexes that are required for phosphorylation of Rb protein and progression of cell cycle to S-phase. 19 DAPI staining indicates that the cytotoxicity induced by rAAVp53 in H-358 cells is mediated by apoptosis. The apoptotic effects of p53 may be mediated by an interaction between bcl-2 family proteins. 20, 21 The growth suppressive effects shown here 
Figure 5 (a) Introduction of rAAVp53 into established H-358 tumor cells in vivo inhibits tumor growth. Athymic nu/nu mice bearing H-358 cells were injected with PBS (n = 5), rAAV control (n = 5) or rAAVp53 (n = 5) 7 days after tumor inoculation. The lines indicate the average tumor size for all animals in each group. Tumor diameter was measured in two perpendicular dimensions using callipers. (b) Percentage of animals with preexisting tumors determined to be tumor-free after treatment is shown as a function of time.

Figure 6 In situ detection of wt p53 by immunohistochemistry. Left panel, uninfected tumor. Tumors were resected, fixed and stained as described in Materials and methods. Middle panel, rAAV control infected tumor; right panel, rAAV p53 infected tumors; arrow, an example of darkly stained nucleus.
expected cytotoxicity from the small fraction of cells products via intercellular gap junctions, 22 endocytosis of apoptotic vesicles from the dying cells by nearby, transduced with the wt p53. This bystander effect has previously been documented in gene transfer experiuntransduced cells, 23 and the inhibition of angiogenesis. 24 The possibility that rAAV itself is toxic to cells is more ments.
8, 22, 23 The molecular basis of this effect is not well understood but may include metabolic transfer of cellular remote given that the rAAV control virus had no effect 680 on tumor growth. However, there are reports of a direct Construction of rAAV The rAAVp53 plasmid was constructed by subcloning anti-oncogenic effect of wt AAV.
25, 26 We confirmed that our recombinant virus preparations were free of wildthe RSV-driven p53 cDNA and the tk-driven neomycin phosphotransferase gene into the XbaI site, between the type AAV.
To date the most common viral vectors for p53 gene two ITR sequences, of the plasmid psub201. rAAV virions were generated by calcium phosphate cotransfectherapy have been recombinant retroviruses and adenoviruses. A therapeutic effect was observed following tion of 10 g of plasmid rAAVp53 and 10 g of helper plasmid (pAAV/Ad) into 293 cells that were infected instillation of a retrovirus carrying wt p53 using an orthotopic human lung cancer model. 27 This study was limited 3 h earlier by the Ad5 virus. Cells were harvested 48 h later, frozen and thawed three times, heat treated (56°C to relatively low viral titers. However, a clinical protocol based on these data observed tumor regression in three for 45 min) to inactivate adenovirus, and centrifuged to remove cellular debris. 33 rAAVcontrol vector carrying of nine patients tested and stabilized tumor growth in an additional three patients. 28 Adenovirus vectors which can cDNA for phox91 (NADPH oxidase) and rAAV␤-gal 32 bearing the ␤-galactosidase gene were generated in a be enriched to produce high titers have been used to transduce a variety of tumor types. Adenovirus encoding similar manner. Titers were performed on D6 cells in the presence of p53 have successfully mediated growth arrest of small cell lung and non-small cell lung tumors both in vitro and 0.5 mg/ml of G418 (Geneticin; GIBCO BRL, Grand Island, NY, USA). Drug-resistant colonies were isolated in vivo. 29, 30 The addition of chemotherapeutic agents in combination with adenovirus p53 facilitated enhanced at 10-14 days. The rAAV titers were calculated from the number of resistant colonies and averaged 0.5-1 × 10 6 tumor apoptosis. 31 However, adenovirus vectors are highly immunogenic in immunocompetent animals neo R infectious particles per milliliter for both rAAV control and rAAVp53, respectively. The titer for rAAV␤-gal which may limit their efficacy and would preclude repeated use.
was 8 × 10 7 infectious particles per ml. The ratio of infectious viral particles to the total viral particles, determined We feel that several of the unique properties of rAAV can be exploited as a safe and efficacious vector for canby viral DNA content, was approximately 1:100. 34 cer gene therapy. 9, 10 As we have shown here, rAAV can efficiently transduce tumor cells. rAAV can be concenHistochemical staining for ␤-gal activity after rAAV␤-gal trated to titers exceeding 10 12 infectious units per ml, is infection nonpathogenic and efficiently transduces most human H-358 cells (5 × 10 5 ) were plated in six-well plates. Cells cancer cells. 8 The high transduction capacity of rAAV were incubated with either rAAV control or rAAV␤-gal may be explained by tropism for tumor-specific memat a MOI of 1 (5 × 10 5 infectious particles) at 37°C for 24 brane receptors. Alternatively, rAAV transduction and h. Plates were washed, fixed with 2% formaldehyde and gene expression occurs in both nondividing and dividing 0.2% glutaraldehyde for 5 min at 4°C, and stained for Xcells typically found in solid tumors. Following transducgal as previously described. 15 The cells were washed tion the rAAV genome may remain episomal or integrate three times in PBS and the enzyme reaction developed in depending on host cellular factors. Regulation of the PBS containing 1 mg/ml of X-gal, 2 mmol/l MgCl 2 , 5 AAV genome state could be potentially useful to restrict mmol/l potassium ferrocyanide, and 5 mmol/l potassgene expression to tumor cells and avoid unwanted ium ferricyanide at 37°C for 24 to 36 h. The cells were expression in normal tissue. Finally, rAAV is a weak then washed in PBS. Individual blue nuclei were counted immunogen and can be administered repeatedly in to estimate the viral titer. immunocompetent animals 32 which may improve efficacy.
In summary, we have constructed a rAAV vector Western blot analysis for p53, p21 and MDM2 H-358 cells (0.5 × 10 6 ) were plated in 6 cm 2 dishes and expressing wt p53 that can effectively inhibit the growth of human cancer cells deficient in the wt p53 gene both incubated the following day with rAAVp53, rAAV control (0.5 × 10 6 infectious particles), or no virus (mock) for in vitro and in vivo. The extent of tumor cell kill argues that a bystander effect may be involved. These results 24 h. Cells were then washed three times with ice cold PBS, scraped and resuspended in 200 l of RIPA lysis encourage future efforts to develop AAV vectors for cancer gene therapy.
buffer (50 mm Tris, pH 7.5, 150 mm NaCl, 1% NP40, 0.5% SDS and 0.1% sodium deoxycholate), and boiled for 10 min. Equal amounts of denatured protein (20 g) were
Materials and methods
electrophoresed on SDS-polyacrylamide gels and transferred to nitrocellulose filters. 35 Filters were blocked with Cell lines and plasmids H-358 cells, derived from bronchoalveolar lung carciphosphate-buffered saline (PBS) containing 5% dried milk and 0.1% Tween 20 (Sigma, St Louis, MO, USA). noma, (kindly provided by J Minna, Southwestern University, Dallas, TX, USA) were grown as previously Blots were probed with 3 g/ml of Ab-2 (Monoclonal mouse IgG) for p53, 3 g/ml of EA 10 antibody for p21, described.
3 These cells carry a homozygous deletion for the p53 gene and are completely devoid of any p53 4 g/ml of IF2 antibody for mdm2, and 3 g/ml of Ab-1 for actin. All the antibodies were obtained from Oncoexpression. The H-358 cells were used because of their reported amenability to adenovirus-mediated gene transgene Science (Uniondale, NY, USA). After incubation with primary antibodies, blots were washed three times fer. 31 Detroit 6 (D6) and 293 cells were maintained as previously described. 33 Plasmids pAAV/Ad, psub 201, with PBS containing 0.1% Tween 20 and then incubated with horseradish peroxidase conjugated anti-mouse secpUC008/NeoR and pREP4 have been previously described. 33 The p53 cDNA was obtained from a plasmid ondary antibody (Amersham, Arlington Heights, IL, USA) for 45 min. Specific complexes were detected by with a pBluescript SK+ backbone. Immunohistochemical stain for p53 expression in tumors infectious particles MOI of 1-2) of rAAVp53 or rAAV H-358 cell (1-2 × 10 5 ) were injected subcutaneously into control for a total duration of 24 h. Cells were treated the shoulder pad of athymic mice. Ten days later, 100 l with trypsin, harvested and counted each day.
of PBS, rAAV control or rAAVp53 were injected into the Cytotoxicity of rAAVp53 was assessed by using a coltumors with a diameter of 4-5 mm 2 . Tumors were harorimetric assay as described previously. 36 H-358 cells (500 vested 5 days after the intratumor injections and fixed in per plate) were plated in each well of a 96-well plate and 10% formalin. Paraffin sections (4 m) were deparaffinincubated with rAAVp53 or rAAV control at increasing ized, cleared and stripped of endogenous peroxidase by concentrations (MOI of 0.1, 1 and 10 infectious particles treatment with 3% hydrogen peroxide in methanol. Secper cell). One week later, cells were fixed using 50% tritions were treated by HIER (steam heat induced epitope chloracetic acid (TCA), washed and air dried. The TCAretrieval solution) for 20 min. Sections were then incufixed cells were then stained for 20 min with 0.4% sulfobated with normal goat serum for 20 min at room temrhodamine B (Sigma) dissolved in 1% acetic acid. The OD perature, primary antibody against wt p53 protein (DO7, at 564 nm was determined using Bio Kinetics reader IgG, 1:25; Dako, Glostrup, Denmark) for 30 min at room EL340 (Bio-Tek Instruments, Frederick, MD, USA) and temperature, biotinylated rabbit anti-mouse immunoconsidered to be related to the total number of surviving globulin G for 45 min at room temperature (Vector Labcells. The survival percentage of rAAV-infected cells was oratories, Burlingame, CA, USA), and avidin-biotinylated calculated by assuming the survival rate of uninfected horseradish peroxidase complex (Vector Laboratories) for cells to be 100%.
25 min at room temperature. Sections were washed thoroughly in phosphate-buffered saline between each of the Cell cycle analysis of rAAVp53 transduced cells immunostaining procedures. The final reaction product H-358 cells (1 × 10 6 ) were plated in six-well dishes and was visualized with diaminobenzidine (Sigma). After infected with rAAVp53 or rAAV control at a MOI of one immunohistochemical reactions, sections were couninfectious particles per cell. Twenty-four hours later, cells terstained with hematoxylin for nuclear detection. 38 For were harvested, stained with propidium iodide and prepositive controls, neoplastic tissues known to be positive pared for flow cytometry by using CycleTest plus DNA for p53 were used. For negative controls, tumors injected reagent kit (Becton Dickinson, San Jose, CA, USA) followwith PBS or rAAV control were used. A brown reaction ing the manufacturer's instructions. 33 Cell cycle phaseproduct in the nucleus indicated specific staining. distribution analysis was performed on an Epics Elite (Coulter Electronics, Hialeah, FL, USA) flow cytometer. Data were analyzed using the Multicycle software pro-as apoptotic. Intact or mitotic nuclei were counted as nant adenovirus expressing WAF1/Cip1 on cell growth, cell normal. were measured twice a week with calipers in two perpen- by the American Association for Accreditation of Labora-
